Molecular profiling reveals unique immune and metabolic features of melanoma brain metastases GM Fischer, A Jalali, DA Kircher, WC Lee, JL McQuade, LE Haydu, ... Cancer discovery 9 (5), 628-645, 2019 | 296 | 2019 |
Intrahepatic cholangiocarcinoma: genomic heterogeneity between eastern and western patients J Cao, J Hu, S Liu, F Meric-Bernstam, R Abdel-Wahab, J Xu, Q Li, M Yan, ... JCO Precision Oncology 4, 557-569, 2020 | 67 | 2020 |
A Preexisting Rare PIK3CAE545K Subpopulation Confers Clinical Resistance to MEK plus CDK4/6 Inhibition in NRAS Melanoma and Is Dependent on S6K1 … G Romano, PL Chen, P Song, JL McQuade, RJ Liang, M Liu, W Roh, ... Cancer discovery 8 (5), 556-567, 2018 | 64 | 2018 |
The immunogenomic landscape of resected intrahepatic cholangiocarcinoma F Carapeto, B Bozorgui, RT Shroff, S Chagani, L Solis Soto, WC Foo, ... Hepatology 75 (2), 297-308, 2022 | 60 | 2022 |
Oral treatment with a rattlesnake native polypeptide crotamine efficiently inhibits the tumor growth with no potential toxicity for the host animal and with suggestive positive … JD Campeiro, MP Marinovic, FC Carapeto, C Dal Mas, GG Monte, ... Amino Acids 50 (2), 267-278, 2018 | 44 | 2018 |
Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy Y Qin, K Bollin, MP De MacEdo, F Carapeto, KB Kim, J Roszik, KM Wani, ... Journal for immunotherapy of cancer 8 (2), 2020 | 43 | 2020 |
Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results IC Glitza Oliva, SD Ferguson, R Bassett Jr, AP Foster, I John, ... Nature medicine 29 (4), 898-905, 2023 | 39 | 2023 |
Spatially resolved analyses link genomic and immune diversity and reveal unfavorable neutrophil activation in melanoma A Mitra, MC Andrews, W Roh, MP De Macedo, CW Hudgens, F Carapeto, ... Nature communications 11 (1), 1839, 2020 | 25 | 2020 |
Molecular profiling reveals unique immune and metabolic features of melanoma brain metastases. Cancer Discov. 2019; 9: 628–645. doi: 10.1158/2159-8290 GM Fischer, A Jalali, DA Kircher, WC Lee, JL McQuade, LE Haydu, ... CD-18-1489.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 25 | |
Long term safety of targeted internalization of cell penetrating peptide crotamine into renal proximal tubular epithelial cells in vivo JD Campeiro, W Dam, GG Monte, LC Porta, LCG Oliveira, MB Nering, ... Scientific reports 9 (1), 3312, 2019 | 19 | 2019 |
Targeting the HGF/MET Axis Counters Primary Resistance to KIT Inhibition in KIT-Mutant Melanoma J Oba, SH Kim, WL Wang, MP Macedo, F Carapeto, MA McKean, ... JCO precision oncology 2, 1-8, 2018 | 18 | 2018 |
The immune landscape of undifferentiated pleomorphic sarcoma R Lazcano, CM Barreto, R Salazar, F Carapeto, RS Traweek, CH Leung, ... Frontiers in Oncology 12, 1008484, 2022 | 17 | 2022 |
Molecular and immunological associations of elevated serum lactate dehydrogenase in metastatic melanoma patients: A fresh look at an old biomarker GM Fischer, FCL Carapeto, AY Joon, LE Haydu, H Chen, F Wang, ... Cancer medicine 9 (22), 8650-8661, 2020 | 16 | 2020 |
Expression of Galectins 1, 3 and 9 in normal oral epithelium, oral squamous papilloma, and oral squamous cell carcinoma TA Hossaka, DA Ribeiro, G Focchi, S André, M Fernandes, FCL Carapeto, ... Dental research journal 11 (4), 508, 2014 | 14 | 2014 |
Tyrosine kinase inhibitor and immune checkpoint inhibitor responses in KIT-mutant metastatic melanoma M McKean, J Oba, J Ma, KG Roth, WL Wang, MP Macedo, FCL Carapeto, ... Journal of Investigative Dermatology 139 (3), 728-731, 2019 | 12 | 2019 |
IDH1 and IDH2 Driven Intrahepatic Cholangiocarcinoma (IHCC): A comprehensive genomic and immune profiling study. S Makawita, MJ Borad, F Carapeto, L Kwong, TS Bekaii-Saab, ... Journal of Clinical Oncology 39 (15_suppl), 4009-4009, 2021 | 11 | 2021 |
IMP dehydrogenase rod/ring structures in acral melanomas GD Keppeke, D Barcelos, M Fernandes, AN Comodo, DP Guimaraes, ... Pigment Cell & Melanoma Research 33 (3), 490-497, 2020 | 11 | 2020 |
Molecular profiling reveals unique immune and metabolic features of melanoma brain metastases. Cancer Discov. 2019; 9 (5): 628–645. doi: 10.1158/2159-8290 GM Fischer, A Jalali, DA Kircher, WC Lee, JL McQuade, LE Haydu, ... CD-18-1489.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 10 | |
Intratumor heterogeneity of KIT gene mutations in acral lentiginous melanoma AN Comodo-Navarro, M Fernandes, D Barcelos, FCL Carapeto, ... The American Journal of Dermatopathology 42 (4), 265-271, 2020 | 9 | 2020 |
Acral lentiginous melanomas harbour intratumor heterogeneity in BRAF exon 15, with mutations distinct from V600E/V600K M Fernandes, D Barcelos, AN Comodo, DP Guimarães, FCL Carapeto, ... The American Journal of Dermatopathology 41 (10), 733-740, 2019 | 8 | 2019 |